Phase III study of vinorelbine plus epirubicin versus epirubicin alone in first-line chemotherapy of metastatic breast cancer:: An Scandinavian breast group study (SBG9403)

被引：0
|
作者：
Ejlertsen, B
Mouridsen, HT
Langkjer, ST
Andersen, J
Sjöström, J
Kjaer, M
机构：
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [21] Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer
    F Cappuzzo
    F Mazzoni
    A Gennari
    S Donati
    B Salvadori
    C Orlandini
    G L Cetto
    A Molino
    E Galligioni
    M Mansutti
    S Tumolo
    A Lucentini
    F Valduga
    S Bartolini
    L Crinò
    P F Conte
    British Journal of Cancer, 2004, 90 : 31 - 35
  • [22] Phase II study of weekly epirubicin and docetaxel as first line chemotherapy in metastatic breast cancer
    Gamucci, Teresa
    D'Ottavio, Anna Maria
    Gareri, Roberta
    Vaccaro, Angela
    Belli, Franca
    Nunziata, Corrado
    Meliffi, Loretta
    Moscetti, Luca
    Barduagni, Mario
    Sperduti, Isabella
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 49
  • [23] Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer
    Luck, HJ
    Thomssen, C
    duBois, A
    Untch, M
    Lisboa, B
    Kohler, G
    Diergarten, K
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 35 - 39
  • [24] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    Gamucci, T.
    D'Ottavio, A. M.
    Magnolfi, E.
    Barduagni, M.
    Vaccaro, A.
    Sperduti, I.
    Moscetti, L.
    Belli, F.
    Meliffi, L.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1040 - 1045
  • [25] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    T Gamucci
    A M D'Ottavio
    E Magnolfi
    M Barduagni
    A Vaccaro
    I Sperduti
    L Moscetti
    F Belli
    L Meliffi
    British Journal of Cancer, 2007, 97 : 1040 - 1045
  • [26] Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
    Blohmer, J. -U.
    Schmid, P.
    Hilfrich, J.
    Friese, K.
    Kleine-Tebbe, A.
    Koelbl, H.
    Sommer, H.
    Morack, G.
    Wischnewsky, M. B.
    Lichtenegger, W.
    Kuemmel, S.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1430 - 1435
  • [27] Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study
    L. Dogliotti
    S. Danese
    A. Berruti
    P. Zola
    T. Buniva
    A. Bottini
    G. Richiardi
    G. Moro
    A. Farris
    M. G. Baù
    G. Porcile
    Cancer Chemotherapy and Pharmacology, 1998, 41 : 333 - 338
  • [28] Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study
    Dogliotti, L
    Danese, S
    Berruti, A
    Zola, P
    Buniva, T
    Bottini, A
    Richiardi, G
    Moro, G
    Farris, A
    Bau, MG
    Porcile, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (04) : 333 - 338
  • [29] Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer
    Vici, P
    Foggi, P
    Colucci, G
    Capomolla, E
    Brandi, M
    Giotta, F
    Gebbia, N
    Di Lauro, L
    Valerio, MR
    Paoletti, G
    Belli, F
    Pizza, C
    Giannarelli, D
    Lopez, M
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1309 - 1314
  • [30] Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer
    Ardizzoia, Antonio
    Colombo, Ilaria
    Giordano, Monica
    Aglione, Stefania
    Isa, Luciano
    Scanni, Alberto
    Scognamiglio, Giovanni
    Bertolini, Alessandro
    Villa, Federica
    Gardani, Gianstefano
    TUMORI JOURNAL, 2007, 93 (06): : 544 - 549
12345